PepGen

Gross Law Firm Notifies PepGen Shareholders of Class Action Lawsuit

NEW YORK, July 10, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of PepGen Inc. PEPG. Shareholders who purchased shares of PEPG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

PepGen Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before August 8, 2025 to Discuss Your RightsPEPG

Robbins LLP is encouraging stockholders of PepGen Inc. (PEPG) who suffered significant losses to contact them regarding a class action lawsuit. The lawsuit pertains to allegations that PepGen misled investors about the effectiveness and safety of its drug candidate PGN-EDO51, leading to a decline in stock prices following safety concerns and a temporary pause in clinical studies. Shareholders interested in serving as lead plaintiffs must file by August 8, 2025. Robbins LLP operates on a contingency fee basis, meaning no fees unless recovery is achieved.

PEPG Stockholders With Large Losses are Encouraged to Contact Robbins LLP for Information About the Securities Class Action Lawsuit Against PepGen Inc.

Investors who suffered losses in PepGen Inc. (PEPG) are urged to contact Levi & Korsinsky for potential recovery under federal securities laws before August 8, 2025. A class action lawsuit alleges securities fraud related to the company's product candidate, PGN-EDO51, claiming it was less effective and safe than represented. The lawsuit seeks to recover losses incurred between March 7, 2024, and March 3, 2025. Interested investors can reach out to the firm for more information without any cost or obligation.

Gross Law Firm Notifies PepGen Shareholders of Class Action Lawsuit

Summary

Impact Analysis